Skip to main content
. 2018 May 15;9(37):24801–24820. doi: 10.18632/oncotarget.24835

Figure 2.

Figure 2

Forest plot of studies assessing (A) Macrophages (B) Macrophages M1 (C) Macrophages M2 and survival in patients with non-small cell lung cancer (NSCLC) stratified according to localisation (in general, tumor or stroma compartment). Adenocarcinoma, ADC; confidence interval, CI; disease specific survival, DSS; hazard ratio, HR; overall survival, OS; programmed cell death-ligand 1, PD-L1; progression free survival, PFS; relapse free survival, RFS; squamous cell carcinoma, SCC.